Zdrowie i gospodarka · 06/09/2013

FDA Releases Draft Guidance on Unique Facility Identifier System for Drug Establishment Registration

The Food and Drug Administration (FDA) has made available a draft guidance outlining the specification of the Unique Facility Identifier (UFI) system for the registration of domestic and foreign drug establishments, in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Food and Drug Administration Safety and Innovation Act (FDASIA).